Incyte Corporation (0J9P.L)
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
$120.28-0.02%
StockGlow Score
Bullish
BearishBullish
1 year ago+61.7%
The outlook
Incyte Corporation currently reads as bullish based on above its 50- & 200-day averages, 90% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Market cap
—
52-wk high
$128.00
52-wk low
$50.81
50-day avg
$60.56
200-day avg
$60.39
Trailing P/E
0.3